Welcome to our dedicated page for Albertsons Companies SEC filings (Ticker: ACI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Albertsons Companies, Inc. (NYSE: ACI) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. As a publicly traded food and drug retailer, Albertsons Companies uses SEC filings to report material events, financing arrangements, governance changes and shareholder matters that are relevant to ACI investors.
Albertsons Companies files current reports on Form 8-K to disclose events such as quarterly earnings releases, senior notes offerings, amendments to its asset-based revolving credit facility, share repurchase agreements and changes in the composition of its board of directors. For example, the company has used Form 8-K to report the issuance of new senior notes due 2031 and 2034, the planned redemption of existing notes, entry into a restated asset-based revolving credit agreement, and the execution of an accelerated share repurchase agreement. Other 8-K filings outline director retirements, new director appointments and results of annual stockholder meetings, including votes on directors, auditor ratification and stockholder proposals.
In addition to 8-Ks, investors typically look to Albertsons Companies’ annual reports on Form 10-K and quarterly reports on Form 10-Q for detailed financial statements, segment information, risk factors and management’s discussion and analysis of operations. These filings provide insight into the company’s supermarket and grocery operations, capital structure, liquidity, covenants under its credit facilities and the terms of its senior notes. Proxy statements referenced in filings offer further detail on governance, executive compensation and related party transactions, including relationships with significant stockholders.
Stock Titan enhances access to ACI filings by pairing real-time updates from the SEC’s EDGAR system with AI-powered summaries that explain key terms and implications. Users can quickly understand complex documents such as credit agreements, indentures for senior notes, share repurchase arrangements and stockholder voting results. The filings page also helps surface information related to insider and major shareholder activity through the SEC reporting framework, giving investors a structured view of Albertsons Companies’ regulatory and capital markets disclosures.
Albertsons Companies, Inc. (ACI) executive Robert Bruce Larson, SVP & Chief Accounting Officer, reported a sale of Class A common stock.
On 10/17/2025, he sold 17,815 shares at $19.75 per share in a single block transaction, as noted in the footnote. Following the sale, he beneficially owns 50,241 shares with direct ownership.
Albertsons Companies (ACI) reported an insider transaction by EVP & Chief HR Officer Michael Theilmann. On October 16, 2025, he sold 100,000 shares of Class A common stock at a weighted‑average price of $19.351.
The filing notes multiple trades executed between $19.34 and $19.40. After these sales, he beneficially owned 338,429 shares directly.
Albertsons Companies (ACI) officer Anuj Dhanda reported an open-market sale of 230,000 shares of Class A common stock at a $19.249 weighted average price on October 16, 2025.
The filing notes executions across a price range of $19.195–$19.295, with details available upon request. After the transaction, Dhanda beneficially owned 300,577 shares, held directly.
Albertsons Companies (ACI) disclosed a Form 144 notice for a proposed sale of up to 17,815 Class A shares with an aggregate market value of $351,849.81. The filing lists Fidelity Brokerage Services LLC as broker and an approximate sale date of 10/17/2025 on the NYSE.
The shares were acquired via restricted stock vesting on 02/22/2025 as compensation. Shares outstanding were 549,307,530.
ACI received a Form 144 notice for a proposed sale of 230,000 shares of common stock with an aggregate market value of $4,427,441.08. The filing lists Fidelity Brokerage Services LLC as broker and the NYSE as the exchange, with an approximate sale date of 10/16/2025.
The shares were acquired through restricted stock vesting on multiple dates—02/26/2022 (37,822), 02/25/2023 (71,806), 02/27/2023 (20,538), 08/05/2024 (99,581), and 08/09/2024 (253)—totaling 230,000. Shares outstanding were 549,307,530.
A selling stockholder filed a Form 144 notice to sell up to 100,000 shares of Class A common stock. The filing lists an aggregate market value of $1,935,144.77, with an approximate sale date of October 16, 2025. The proposed sales would be executed through Fidelity Brokerage Services LLC on the NYSE.
The shares were acquired via restricted stock vesting from the issuer as compensation, in lots of 2,500 (06/26/2020), 14,395 (02/27/2021), 23,546 (05/05/2021), 19,070 (08/19/2021), and 40,489 (02/26/2022), totaling 100,000 shares. The filing table also lists 549,307,530 shares outstanding; this is a baseline figure, not the amount being offered.
Albertsons Companies (ACI) entered an accelerated share repurchase (ASR) with JPMorgan to repurchase $750 million of common stock as part of its buyback program. The company will pay $750 million on October 15, 2025, and expects an initial delivery of approximately 80% of the shares initially underlying the ASR.
The final number of shares will be determined by the volume‑weighted average price of ACI stock during the ASR term, less a discount, with customary adjustments. The transactions are expected to be completed no later than the first quarter of 2026. The Board also increased the total share repurchase authorization to $2.75 billion, inclusive of this ASR.
Albertsons Companies (ACI) reported steady second‑quarter results. Net sales and other revenue were $18.9 billion, up 2.0% year over year, with net income $168.5 million and EPS $0.30. Identical sales excluding fuel rose 2.2%, driven primarily by strong pharmacy growth. Digital sales increased 23%, and loyalty members grew 13% to 48.7 million.
Gross margin rate was 27.0% versus 27.6% a year ago, reflecting mix shift toward pharmacy and higher delivery and handling costs from digital, partially offset by productivity initiatives. For the first 28 weeks of fiscal 2025, cash from operations totaled $1,282.0 million; capital expenditures were $950.5 million.
Capital returns included $169.6 million in dividends and repurchase of 25.7 million shares for $550.1 million. Subsequent to quarter end, ACI entered a $750 million accelerated share repurchase and increased its authorization to $2.75 billion. The company issued $600 million 6.250% notes due 2033 to redeem 2026 notes and amended its $4.0 billion ABL facility to extend maturity to 2030, with $325.0 million outstanding. A pension annuity purchase transferred $290.0 million of assets, resulting in a $26.8 million settlement gain.
Albertsons Companies, Inc. (ACI) furnished a press release announcing its financial results for the 12 and 28 weeks ended September 6, 2025. The press release is provided as Exhibit 99.1. The company noted that this information is furnished and not deemed filed under the Exchange Act, and is not incorporated by reference except as expressly set forth by specific reference.
Albertsons Companies, Inc. (ACI) director David Zinsner was granted 4,603 time-based restricted stock units (RSUs) on 09/23/2025. Each RSU represents a contractual right to receive one share of Class A common stock.
The award will vest in full on February 28, 2026 provided Zinsner continues to serve as a director through that date. The Form 4 was signed on behalf of Mr. Zinsner by Maria Fernandez on 09/24/2025.